What is Pmv Pharmaceuticals Inc?
, a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 95.93M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.